Portal de Periódicos da CAPES

Schizophrenia: Some Current Neurochemical Approaches

1983; Wiley; Volume: 41; Issue: 1 Linguagem: Inglês

10.1111/j.1471-4159.1983.tb11809.x

1471-4159

Richard Rodnight,

Ion channel regulation and function

Journal of NeurochemistryVolume 41, Issue 1 p. 12-21 Schizophrenia: Some Current Neurochemical Approaches Richard Rodnight, Corresponding Author Richard Rodnight Department of Biochemistry, Institute of Psychiatry, London, U.K.Address correspondence and reprint requests to Dr. Richard Rodnight, Department of Biochemistry, Institute of Psychiatry, De Crespigny Park, London SE5 8AF. U.K.Search for more papers by this author Richard Rodnight, Corresponding Author Richard Rodnight Department of Biochemistry, Institute of Psychiatry, London, U.K.Address correspondence and reprint requests to Dr. Richard Rodnight, Department of Biochemistry, Institute of Psychiatry, De Crespigny Park, London SE5 8AF. U.K.Search for more papers by this author First published: January 1983 https://doi.org/10.1111/j.1471-4159.1983.tb11809.xCitations: 29Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Andreasen N. C. , Smith M. R. , Jacoby C. G. , Dennert J. W. , and Olsen S. A. ( 1982a ) Ventricular enlargement in schizophrenia: Definition and prevalence . Am. J. Psychiatry 139 , 292 – 296 . Andreasen N. C. , Olsen S. A. , Dennert J. W. , and Smith M. R. ( 1982b ) Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms . Am. J. Psychiatry 139 , 297 – 302 . Baldessarini R. J. ( 1977 ) Schizophrenia . N. Engl. J. Med. , 297 , 988 – 995 . Baldessarini R. J. , Stramentinoli G. , and Lipinski J. F. ( 1979 ) Methylation hypothesis . Arch. Gen. Psychiatry 36 , 303 – 307 . Bennett , J. P. Jr. , Enna , S. J. , Bylund D. B. , Gillin J. C. , Wyatt , R. J. , and Snyder , S. H. ( 1979 ) Neurotransmitter receptors in frontal cortex of schizophrenics . Arch. Gen. Psychiatry 36 , 927 – 934 . Berger P. A. ( 1981 ) Biochemistry and the schizophrenias. Old concepts and new hypotheses . J. Nerv. Ment. Dis ., 169 , 90 – 99 . Besson J. A. O. ( 1980 ) A diagnostic pointer to adult meta-chromatic leucodystrophy . Br. J. Psychiatry 137 , 186 – 187 . Bickel P. , Dittrich A. , and Dchopf J. ( 1976 ) Experimental study on altered states of consciousness induced by N, N- dimethyltryptamine (DMT) . Pharmacopsychiatr. Neuro-psychopharmakol . 9 , 220 – 225 . Bird E. D. , Spokes E. G. S. , and Iversen L. L. ( 1979 ) Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia . Brain 102 , 347 – 360 . Book J. A. , Wetterberg L. , and Modrezewska K. ( 1978 ) Schizophrenia in a North Swedish geographical isolate, 1900–1977. Epidemiology, genetics and biochemistry . Clin. Genet . 14 , 373 – 394 . Bowers , M. B. Jr. ( 1974 ) Central dopamine turnover in schizophrenic syndromes . Arch. Gen. Psychiatry 31 , 50 – 54 . Bowers , M. B. Jr. , Gold , B. I. , and Roth R. H. ( 1980 ) CSF GABA in psychotic disorders . Psychopharmacology 70 , 279 – 282 . Breakefield X. O. , Cawthon R. M. , Casto-Costa M. R. , Edel-stein S. B. , and Hawkins , M. Jr. ( 1979 ) A genetic view of monoamine oxidase . Soc. Neurosci. Symp . 4 , 43 – 66 . Buchsbaum M. S. , and Haier P. J. ( 1978 ) Biological homogeneity, symptom heterogeneity and the diagnosis of schizophrenia . Schizophr. Bull. 4 , 473 – 475 . Carenzi A. , Gillin C. , Guidotti A. , Schwartz M. A. , Trabucchi M. , and Wyatt R. J. ( 1975 ) Dopamine sensitive adenylyl cy-clase in human caudate nucleus . Arch. Gen. Psychiatry 32 , 1056 – 1059 . Castellani S. , Ziegler M. G. , van Kammen D. P. , Alexander P. E. , Sins S. G. , and Lake C. R. ( 1982 ) Plasma norepineph-rine and dopamine-β-hydroxylase activity in schizophrenia . Arch. Gen. Psychiatry 39 , 1145 – 1149 . Checkley S. A. , Oon M. C. H. , Rodnight R. , Murphy M. P. , Williams R. S. , and Birley J. L. T. ( 1979 ) Urinary excretion of dimethyltryptamine in liver disease . Am. J. Psychiatry 136 , 439 – 441 . Checkley S. A. , Murray R. M. , Oon M. C. H. , Rodnight R. , Murphy M. P. , and Birley J.L. T. ( 1980 ) A longitudinal study of the excretion of N, N-dimethyltryptamine in patients with psychotic illness . Br. J. Psychiatry 137 , 236 – 239 . Clow A. , Theodorou A. , Jenner P. , and Marsden C. D. ( 1980a ) Changes in rat striatal dopamine turnover and receptor activity during one years' neuroleptic administration . Eur. J. Pharmacol . 63 , 135 – 144 . Clow A. , Theodorou A. , Jenner P. , and Marsden C. D. ( 1980b ) Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration . Eur. J. Pharmacol . 63 , 145 – 157 . Cross A. J. , Crow T. J. , Killpack W. S. , Longden A. , Owen F. and Riley G. J. ( 1978 ) The activities of brain dopamine-β-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls . Psychopharmacology 59 , 117 – 121 . Cross A. J., Crow T. J., and Owen F. (1979) Gamma-amino butyric acid in the brain in schizophrenia. Lancet I, 500–561 . Cross A. J. , Crow T. J. , and Owen F. ( 1981 ) 3H-Flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D-2 receptors . Psychopharmacology 74 , 122 – 124 . Crow T. J. ( 1981 ) Biological basis of mental disorders: The case for a viral aetiology , in Epidemiological Impact of Psycho-tropic Drugs ( G. Tognoni , C. Bellantuono , and M. Lader , eds. ) pp. 33 – 51 . Elsevier/North-Holland , Amsterdam . Crow T. J. (1982) Two syndromes in schizophrenia? Trends Neurosci. 5, 351–354 . Crow T. J. ( 1983 ) Is schizophrenia an infectious disease ? Lancet 1 , 173 – 175 . Crow T. J. , Baker H. F. , Cross A. J. , Joseph M. H. , Lofthouse R. , Longden A. , Owen F. , Riley G. J. , Glover V. , and Killpack W. S. ( 1979 ) Monoamine mechanisms in chronic schizophrenia: Post mortem neurochemical findings . Br. J. Psychiatry 134 , 249 – 256 . Crow T. J. , Owen F. , Cross A. J. , Johnstone E. C. , Joseph M. H. , and Longeden A. ( 1980 ) The dopamine receptor as the site of the primary disturbance in the Type 1 syndrome of schizophrenia , in Enzymes and Neurotransmitters in Mental Disease ( E. Usdin , T. L. Sourkes , and M. B. H. Youdim , eds. ), pp. 559 – 572 . John Wiley , Chichester . Curzon G. , Kantamaneni B. D. , van Voxel P. , Gillman P. K. , Partlett J. R. , and Bridges P. K. ( 1980 ) Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients . Acta Psychiatr. Scand . [ Suppl. ] 280 , 3 – 19 . Davison K. and Bagley C. R. ( 1969 ) Schizophrenia-like psychoses associated with organic disorders of the central nervous system: A review of the literature , in Current Problems of Neuropsychiatry ( Br. J. Psychiatry , Special Publication No. 4 ; R. N. Herrington , ed. ), pp. 113 – 184 . Headley , Ashford , Kent . De Lisi L. E. , Wise C. D. , Potkin S. G. , Zalcman S. , Phelps B. H. , Lovenberg W. and Wyatt R. J. ( 1980 ) Dopamine-β-hydroxylase, monoamine oxidase and schizophrenia . Biol. Psychiatry 15 , 899 – 907 . De Lisi , L. E. , Neckers , L. M. , Weinberger D. R. , and Wyatt R. J. ( 1981 ) Increased whole blood serotonin concentrations in chronic schizophrenic patients . Arch. Gen. Psychiatry 38 , 647 – 650 . Farley I. J. , Price K. S. , McCullough E. , Deck J. N. , Hordynski W. , and Hornykiewicz O. ( 1978 ) Norepinephrine in chronic paranoid schizophrenia: Above normal levels in limbic forebrain . Science 200 , 465 – 468 . Freedman D. X. , Belendruk K. , Belendruk B. W. , and Crayton J. W. ( 1981 ) Blood tryptophan metabolism in chronic schizophrenics . Arch. Gen. Psychiatry 38 , 655 – 659 . Freeman J. M. , Finkelstein J. D. , and Mudd S. H. ( 1975 ) Folate responsive homocystinuria and schizophrenia . N. Engl. J. Med. 292 , 491 – 496 . Fujita K. , Ito T. , Maruta K. , Teradaisa R. , Beppu H. , Nakagami Y. , Kato Y. , Nagatsu T. , and Kato T. ( 1978 ) Serum dopamine-β-hydroxylase in schizophrenic patients . J. Neurochem . 30 , 1569 – 1572 . Gillin J. C. , Kaplan J. , Stillman R. , and Wyatt R. J. ( 1976 ) The psychodelic model of schizophrenia—the case of N, N- dimethyltryptamine . Am. J. Psychiatry 133 , 203 – 208 . Gillin J. C. , Stoff D. M. , and Wyatt R. J. ( 1978 ) Transmethyla-tion hypothesis: A review of progress , in Psychopharmcology: A Generation of Progress ( M. A. Lipton , A. Mascio , and K. F. Killam , eds. ), pp. 1097 – 1112 . Raven Press , New York . Gomes U. C. R. and Shanley B. C. ( 1978 ) Endogenous inhibitor of indo[eamine-N-methyltransferase in cerebrospinal fluid . Life Sci . 23 , 697 – 704 . Gomes U. C. R. , Shanley B.C. , Potgieter L. , and Roux J. T. ( 1980 ) Noradrenergic overactivity in chronic schizophrenia: Evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations . Br. J. Psychiatry 137 , 346 – 351 . Gruen P. H. , Sachar E. J. , Langer G. , Altman N. , Leifer M. , Frantz A. , and Halpern F. S. ( 1978 ) Prolactin responses to neuroleptics in normal and schizophrenic subjects . Arch. Gen. Psychiatry 35 , 108 – 116 . Hare E. ( 1982 ) Epidemiology of schizophrenia , in Handbook of Psychiatry, Vol. 3: Psychoses of Uncertain Aetiology ( J. K. Wing , ed. ), pp. 42 – 48 . Cambridge University Press , Cambridge . Hornykiewicz O. ( 1982 ) Brain catecholamines in schizophrenia—a good case for noradrenaline . Nature 299 , 484 – 486 . Hussein L. , Sindarto E. , and Goedele H. W. ( 1980 ) Twin studies and substrate differences in platelet monoamine oxidase activity . Hum. Hered . 30 , 65 – 70 . Jackman H. C. and Meltzer H. Y. ( 1980 ) Factors affecting determination of platelet monoamine oxidase activity . Schizophr. Bull. 6 , 259 – 265 . Jenner P. , Marsden C. D. , and Thanki C. M. ( 1980 ) Behavioural changes induced by N, N-dimethyltryptamine in rodents . Br. J. Pharmacol . 69 , 69 – 80 . Jeste D. V. , Kleinman J. E. , Potkin S. G. , Luchins D. J. , and Weinberger D. R. ( 1982 ) Ex uno multi-subtyping the schizophrenic syndrome . Biol. Psychiatry 17 , 199 – 222 . Johnstone E. C. , Crow T. J. , Frith C. D. , Husband J. , and Kreel L. ( 1976 ) Cerebral ventricular size and cognitive impairment in chronic schizophrenia . Lancet ii , 924 – 926 . Johnstone E. , Crow T. J. , and Mashiter K. ( 1977 ) Anterior pituitary hormone secretion in schizophrenia—an approach to neurohumoral mechanisms . Psychol. Med. 7 , 223 – 228 . Joseph M. H. , Baker H. F. , Crow T. J. , Riley G. L. , and Risby D. ( 1979 ) Tryptophan metabolism in schizophrenia: A post mortem study of the serotonin and kynurenine pathways in schizophrenic and control subjects . Psychopharmacology 62 , 279 – 285 . Kaplan J. , Mandel J. R. , Stillman R. , Walker R. W. , Van-denheuvel W. J. A. , Gillin J. C. , and Wyatt R. J. ( 1974 ) Blood and urine levels of N, N-dimethyltryptamine following administration of psychoactive doses to human subjects . Psychopharmacologia 38 , 239 – 245 . Karoum F. , Nasrallah H. , Potkin S. , Chuang L. , Moyer-Schwing J. , Phillips I. , and Wyatt R. J. ( 1979 ) Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain . J. Neurochem . 33 , 201 – 212 . Kemali D. , Del Vecchio , M. , and Maj M. ( 1982 ) Increased noradrenaline levels in CSF and plasma of schizophrenic patients . Biol. Psychiatry 17 , 711 – 717 . Kendler K. S. and Davis K. L. ( 1981 ) The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses . Schizophr. Bull. 7 , 689 – 709 . Kety S. S. ( 1978 ) The biology of abnormal mental states . Fed. Proc . 37 , 2267 – 2270 . Kety S. S. ( 1980 ) The syndrome of schizophrenia: Unresolved questions and opportunities for research . Br. J. Psychiatry 136 , 421 – 436 . Kleinman J. E. , Weinberger D. R. , Rogol A. D. , Bigelow L. A. , Klein S. T. , Gillin J. C. , and Wyatt R. J. ( 1982 ) Plasma pro-lactin concentrations and psychopathology in chronic schizophrenia . Arch. Gen. Psychiatry 39 , 655 – 657 . Lee T. and Seeman P. ( 1980 ) Elevation of brain neuroleptic/ dopamine receptors in schizophrenia . Am. J. Psychiatry 137 , 191 – 197 . Lewis M. E. ( 1980 ) Biochemical aspects of schizophrenia . Es-says Neurochem. Neuropharmacol . 4 , 1 – 67 . Lichtshtein D. , Dobkin J. , Ebstein R. P. , Biederman J. , Rimon R. , and Belmaker R. H. ( 1978 ) GABA in the CSF of schizophrenic patients before and after neuroleptic treatment . Br. J. Psychiatry 132 , 145 – 148 . Lishman W. A. ( 1978 ) Organic Psychiatry . The Psychological Consequences of Cerebral Disorder . Blackwell Scientific Publications , Oxford . Mackay A. V. P. , Iversen L. L. , Rossor M. , Spokes E. , Bird E. , Arregui A. , Creese I. , and Snyder S. H. ( 1982 ) Increased brain dopamine and dopamine receptors in schizophrenia . Arch. Gen. Psychiatry 39 , 991 – 997 . Manowitz P. , Kling A. , and Kohn H. ( 1978 ) Clinical course of adult metachromatic leukodystrophy presenting as schizophrenia . J. Nerv. Ment. Dis . 166 , 500 – 506 . Marsden C. D. and Jenner P. ( 1980 ) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs . Psychol. Med. 10 , 55 – 72 . McCarthy B. W. , Gomes U. R. , Neethling A. C. , Shanley B. C. , Taljaard J. J. F. , Potgieter L. , and Roux J. T. ( 1981 ) γ-Aminobutyric acid concentration in cerebrospinal fluid in schizophrenia . J. Neurochem . 36 , 1406 – 1408 . Meltzer H. Y. ( 1979 ) Biochemical studies in schizophrenia , in Disorder of the Schizophrenic Syndrome ( L. Bellak , ed. ), pp. 45 – 133 . Basic Books , New York . Meltzer H. Y. , Nasr S. J. , and Tong C. ( 1980 ) Serum dopamine-β-hydroxylase activity in schizophrenia . Biol. Psychiatry 15 , 781 – 788 . Meltzer H. Y. , Perline R. , and Lewine R. ( 1982 ) Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine induced growth hormone response . J. Nerv. Ment. Dis . 170 , 758 – 765 . Moja E. A. , Stolt D. M. , Gillin J. C. L. , and Wyatt R. J. ( 1978 ) Neuroleptics attenuate stereotyped behaviour induced by β-phenylethylamine in rats . Biol. Psychiatry 13 , 291 – 295 . Murray R. M. , Oon M. C. H. , Rodnight R. , Birley J. L. T. , and Smith A. ( 1979 ) Increased excretion of dimethyltryptamine and certain features of psychosis . Arch. Gen. Psychiatry 36 , 644 – 649 . Murugaiah K. , Theodorou A. , Mann S. , Clow A. , Jenner P. , and Marsden C. D. ( 1982 ) Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum . Nature 296 , 570 – 572 . Osmond H. and Smythies J. R. ( 1952 ) Schizophrenia: A new approach . J. Ment. Sci . 98 , 309 – 315 . Owen F. , Crow T. J. , Poulter M. , Cross A. J. , Longden A. , and Riley G. J. ( 1978 ) Increased dopamine receptor sensitivity in schizophrenia . Lancet ii , 223 – 226 . Owen F. , Cross A. J. , Poulter M. , and Waddington J. L. ( 1979 ) Changes in characteristics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration. Effect of buffer washing of membranes . Life Sci . 25 , 385 – 390 . Owen F. , Bourne R. C. , Crow T. J. , Fadhli A. A. , and Johnstone E. C. ( 1981a ) Platelet monoamine oxidase activity in acute schizophrenia: Relationship to symptomatology and neuroleptic mediation . Br. J. Psychiatry 139 , 16 – 22 . Owen F. , Cross A. J. , Crow T. J. , Poulter M. , and Waddington J. L. ( 1981b ) Increased dopamine receptors in schizophrenia: Specificity and relationship to drugs and symptomatology , in Biological Psychiatry 1981 ( C. Perris , G. Struwe , and B. Jansson , eds. ), pp. 699 – 706 . Elsevier/ North-Holland , Amsterdam . Pepplinkhuizen L. , Bruinvels J. , Blom W. , and Moleman P. ( 1980 ) Schizophrenia-like psychosis caused by a metabolic disorder . Lancet 1 , 454 – 456 . Potkin S. G. , Karoum F. , Chuang L-W. , Cannon-Spoor H. E. , Phillips I. , and Wyatt R. J. ( 1979 ) Phenylethylamine in paranoid schizophrenia . Science 206 , 470 – 471 . Potkin S. G. , Weinberger D. R. , Linnoila M. , and Wyatt R. J. ( 1983 ) Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles . Am. J. Psychiatry 140 , 21 – 25 . Randrup A. and Munkvard I. ( 1972 ) Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain . Orthomol. Psychiatry 1 , 2 – 7 . Reveley A. M. , Reveley M. A. , Clifford C. A. , and Murray R. M. ( 1982 ) Cerebral ventricular size in twins discordant for schizophrenia . Lancet I , 540 – 541 . Reveley M. A. , Reveley A. M. , Clifford C. A. , and Murray R. M. ( 1983 ) The genetics of platelet MAO activity in schizophrenic and normal twins. Br. J. Psychiatry (in press) . R. Rodnight ( 1980 ) Biochemical perspectives in psychiatric research, in Priorities in Psychiatric Research ( M. H. Lader , ed. ), pp. 1 – 16 . John Wiley , Chichester . Rodnight R. ( 1982 ) Biochemistry and pathology of schizophrenia , in Handbook of psychiatry, Vol. 3: Psychoses of Uncertain Aetiology . ( J. K. Wing , ed. ), pp. 69 – 73 . Cambridge University Press , Cambridge . Rotrosen J. , Angrist B. , Gershon S. , Paquin J. , Branchey L. , Oleshansky M. , Halpern F. , and Sachar E. J. ( 1979 ) Neuroendocrine effects of apomorphine: Characterization of response patterns and application to schizophrenia research . Br. J. Psychiatry 135 , 444 – 456 . Sandier M. ( 1980 ) Trace amines in schizophrenia , in Enzymes and Neurotransmitters in Mental Disease ( E. Usdin , T. L. Sourkes , and M. B. H. Youdim , eds. ), pp. 95 – 101 . John Wiley , Chichester . Sandier M. , Reveley M. A. , and Glover V. ( 1981 ) Human platelet monoamine oxidase in health and disease: A review . J. Clin. Pathol . 34 , 292 – 302 . Slater E. and Cowie V. ( 1971 ) The Genetics of Mental Disorders . Oxford University Press , London . Smith T. L. ( 1977 ) Increased synthesis of striatal DA by N, N-DMT . Life Sci . 21 , 1597 – 1602 . Snyder S. H. ( 1973 ) Amphetamine psychosis, a “model” schizophrenia mediated by catecholamines . Am. J. Psychiatry 130 , 61 – 67 . Stahl S. M. , Woo D. J. , Mefford I. N. , Berger PA. , and Ciaranello R. D. ( 1983 ) Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders . Am. J. Psychiatry 140 , 26 – 30 . Sternberg D. E. , van Kammen D. P. , Lake C. R. , Ballenger J. C. , Morder S. R. , and Bunney , W. E. Jr. ( 1981 ) The effect of pimozide on CSF norepinephrine in schizophrenia . Am. J. Psychiatry 138 , 1045 – 1050 . Sternberg D. E. , Charney D. S. , Heninger G. R. , Leckman J. F. , Hafstad K. M. , and Londis D. H. ( 1982 ) Impaired pre-synaptic regulation of norepinephrine in schizophrenics . Arch. Gen. Psychiatry 39 , 285 – 289 . Stevens J. R. ( 1982 ) Neuropathology of schizophrenia . Arch. Gen. Psychiatry 39 , 1131 – 1139 . Stolk J. M. , Hurst J. H. , Friedman M. J. , Harris P. W. , van Riper D. A. , and Nisula B. C. ( 1980 ) Serum dopamine-β-hydroxylase: Indicator of what ? in Enzymes and Neurotransmitters in Mental Disease ( E. Usdin , T. L. Sourkes , and M. B. H. Youdim , eds. ), pp. 171 – 192 . John Wiley , Chichester . Stramentinoli G. and Baldessarini R. J. ( 1978 ) Lack of enhancement of DMT formation in rat brain and rabbit lung in vivo by methionine or 5-adenosylmethionine . J. Neurochem . 31 , 1015 – 1020 . Torrey E. F. and Peterson M. R. ( 1976 ) The viral hypothesis of schizophrenia . Schizophr. Bull. 2 , 136 – 146 . Tyrrell D. A. J. , Parry R. P. , Crow T. J. , Johnstone E. , and Fer-rier I. N. ( 1979 ) Possible virus in schizophrenia and some neurological disorders . Lancet I , 839 – 841 . van Kammen D. P. , Sternberg D. E. , Hare T. A. , and Waters R. N. ( 1982 ) CSF levels of γ-aminobutyric acid in schizophrenia . Arch. Gen. Psychiatry 39 , 91 – 97 . Waldmeier P. E. , and Maitre L. ( 1977 ) Neurochemical investigations of the interaction of N, N-dimethyltryptamine with the dopaminergic system in rat brain . Psvchopharmacology 52 , 137 – 144 . Walker R. W. , Mandel L. R. , Kleinman J. E. , Gillin J. C. , Wyatt R. J. , and Vandenheuvel W. J. A. ( 1979 ) Improved selective ion monitoring mass-spectrometric assay for the determination of N, N-dimethyltryptamine in human blood utilizing capillary column gas chromatography . J. Chromatogr . 162 , 539 – 546 . Weinberger D. R. , Torrey E. F. , Neophytides A. N. , and Wyatt R.J. ( 1979 ) Lateral cerebral ventricular enlargement in chronic schizophrenia . Arch. Gen. Psychiatry 36 , 735 – 739 . Winter H. , Herschel M. , Propping P. , Friedl W. , and Vogel F. ( 1978 ) A twin study of three enzymes (DBH, COMT, MAO) of catecholamine metabolism . Psychopharmacology 57 , 63 – 69 . Wise C. D. , Baden M. M. , and Stein L. ( 1974 ) Post mortem measurements of enzymes in human brain: Evidence of a central noradrenergic deficit in schizophrenia . J. Psychiatr. Res . 11 , 185 – 198 . Wyatt R. J. , Murphy D. L. , Belmaker R. , Cohen S. , Donnelly C. H. , and Pollin , W. ( 1973 ) Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia . Science 179 , 916 – 918 . Wyatt R. J. and Bigelow L. B. ( 1978 ) A survey of biological research in schizophrenia , in Nature oj Schizophrenia ( L. C. Wynne , R. L. Cromwell , and S. Matthyse , eds. ). pp. 143 – 147 . John Wiley . New York . Wyatt R. J. , Potkin S. G. , and Murphy D. L. ( 1979 ) Platelet monoamine oxidase activity in schizophrenia: A review of the data . Am. J. Psychiatry 136 , 377 – 385 . Wyatt R. J. , Potkin S. G. , Kleinman J. E. , Weinberger D. R. , Luchins D. J. , and Jeste D. V. ( 1981 ) The schizophrenia syndrome. Examples of biological tools for subclassifica-tion . J. Nerv. Ment. Dis . 169 , 100 – 112 . Citing Literature Volume41, Issue1January 1983Pages 12-21 ReferencesRelatedInformation